IQV
HealthcareIQVIA Holdings Inc.
$234.59
+$9.22 (+4.09%)
Jan 5, 2026
Price History (1Y)
Analysis
IQVIA Holdings Inc. is a company in the healthcare sector, specifically operating within the diagnostics and research industry. The company has a substantial scale, with a market capitalization of $39.95 billion, revenue of $15.90 billion (TTM), and approximately 91,000 employees. The company's financial health indicates strong profitability, with gross margins at 33.8%, operating margin at 14.0%, and profit margin at 8.1%. Returns on equity and assets are also notable, at 19.4% and 5.1%, respectively. The balance sheet shows a significant debt burden of $15.24 billion, but a substantial cash reserve of $1.97 billion. The company's valuation is characterized by a price-to-earnings ratio (TTM) of 30.95 and forward P/E of 18.13. Revenue growth has been moderate at 5.2% year-over-year, while earnings growth has been stronger at 24.5%. The absence of dividend information precludes analysis in this regard.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About IQVIA Holdings Inc.
IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. It has a strategic collaboration with Sarah Cannon Research Institute to enhance clinical trial processes. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is based in Durham, North Carolina.
Visit website →Key Statistics
- Market Cap
- $39.95B
- P/E Ratio
- 30.95
- 52-Week High
- $234.95
- 52-Week Low
- $134.65
- Avg Volume
- 1.48M
- Beta
- 1.37
Company Info
- Industry
- Diagnostics & Research
- Exchange
- NYQ
- Country
- United States
- Employees
- 91,000